The purpose of this study is to determine the possible effect nephroprotective of
N-acetylcysteine in patients with chronic kidney disease undergoing elective coronary artery
bypass grafting by serial evaluation of renal function and to evaluate whether treatment
reduces cardiac mortality, cardiac events and Global mortality, if it interferes with
oxidative stress and inflammation and the need for dialysis.
Phase:
N/A
Details
Lead Sponsor:
Instituto do Coracao
Collaborator:
Fundação de Amparo à Pesquisa do Estado de São Paulo